Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi Fei Cheng

Showing results (31-40 of 88) with videos related to

Pageof 9
Sort By:
Angewandte Chemie (International Ed. in English)|March 9, 2023
Simple and Versatile Nitrooxylation: Noncyclic Hypervalent Iodine Nitrooxylating ReagentXuan Cheng, Quan Yin, Yu-Xuan Jiang, et al.
Clinical Immunology (Orlando, Fla.)|April 27, 2026
The impact of pre-existing autoimmune diseases in myelodysplastic syndrome patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective cohort studyNing Wu, Jing Liu, Meng Lv, et al.
Bone Marrow Transplantation|July 17, 2025
Characteristics and prognosis of central nervous system relapse after allogeneic hematopoietic stem cell transplantation in adult patients with leukemiaLi-Ping Guo, Li-Juan Hu, Xiao-Dong Mo, et al.
European Journal of Haematology|January 21, 2026
Bridging With Chimeric Antigen Receptor T-Cell Therapy or Chemotherapy to Allo-HSCT in B-ALL: A Comparison of Treatment Complications and SurvivalNing Wu, Jun Kong, Meng Lv, et al.
Bone Marrow Transplantation|March 19, 2026
Donor age ≥50 years combined with donor-CI ≥3 identifies a high-risk cohort for adverse outcomes after allogeneic hematopoietic stem cell transplantation in B-cell acute lymphoblastic leukemiaNing Wu, Jun Kong, Meng Lv, et al.
Leukemia & Lymphoma|December 3, 2023
Outcomes of haploidentical hematopoietic stem cell transplantation with 'Beijing protocol' in pediatric myeloid neoplasms post cytotoxic therapy: a case series studyFeng Zhang, Guan-Hua Hu, Le-Ping Zhang, et al.
Nature Communications|June 10, 2024
Enantioselective copper-catalyzed azidation/click cascade reaction for access to chiral 1,2,3-triazolesLing-Feng Jiang, Shao-Hua Wu, Yu-Xuan Jiang, et al.
Transplantation and Cellular Therapy|October 31, 2025
Prophylactic Versus Preemptive Donor Lymphocyte Infusion in Refractory/Relapsed AML Post-Allogeneic Transplant: A Retrospective Comparative StudyNing Wu, Chen-Hua Yan, Jun Kong, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 1, 2006
[Clinical significance for minimal residual disease detection by 4 color flow cytometry in adult and childhood B lineage acute lymphoblastic leukemia]Yan-rong Liu, Le-ping Zhang, Yan Chang, et al.
Transplantation and Cellular Therapy|February 10, 2026
Desensitization therapy using sirolimus and anti-CD20 monoclonal antibody based regimen in haploidentical transplant recipients positive for donor-specific anti-HLA antibodiesNing Ma, Xiang-Yu Zhao, Lan-Ping Xu, et al.
Pageof 9

Showing results (31-40 of 88) with videos related to

Sort By:
Pageof 9
Angewandte Chemie (International Ed. in English)|March 9, 2023
Simple and Versatile Nitrooxylation: Noncyclic Hypervalent Iodine Nitrooxylating ReagentXuan Cheng, Quan Yin, Yu-Xuan Jiang, et al.
Clinical Immunology (Orlando, Fla.)|April 27, 2026
The impact of pre-existing autoimmune diseases in myelodysplastic syndrome patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective cohort studyNing Wu, Jing Liu, Meng Lv, et al.
Bone Marrow Transplantation|July 17, 2025
Characteristics and prognosis of central nervous system relapse after allogeneic hematopoietic stem cell transplantation in adult patients with leukemiaLi-Ping Guo, Li-Juan Hu, Xiao-Dong Mo, et al.
European Journal of Haematology|January 21, 2026
Bridging With Chimeric Antigen Receptor T-Cell Therapy or Chemotherapy to Allo-HSCT in B-ALL: A Comparison of Treatment Complications and SurvivalNing Wu, Jun Kong, Meng Lv, et al.
Bone Marrow Transplantation|March 19, 2026
Donor age ≥50 years combined with donor-CI ≥3 identifies a high-risk cohort for adverse outcomes after allogeneic hematopoietic stem cell transplantation in B-cell acute lymphoblastic leukemiaNing Wu, Jun Kong, Meng Lv, et al.
Leukemia & Lymphoma|December 3, 2023
Outcomes of haploidentical hematopoietic stem cell transplantation with 'Beijing protocol' in pediatric myeloid neoplasms post cytotoxic therapy: a case series studyFeng Zhang, Guan-Hua Hu, Le-Ping Zhang, et al.
Nature Communications|June 10, 2024
Enantioselective copper-catalyzed azidation/click cascade reaction for access to chiral 1,2,3-triazolesLing-Feng Jiang, Shao-Hua Wu, Yu-Xuan Jiang, et al.
Transplantation and Cellular Therapy|October 31, 2025
Prophylactic Versus Preemptive Donor Lymphocyte Infusion in Refractory/Relapsed AML Post-Allogeneic Transplant: A Retrospective Comparative StudyNing Wu, Chen-Hua Yan, Jun Kong, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 1, 2006
[Clinical significance for minimal residual disease detection by 4 color flow cytometry in adult and childhood B lineage acute lymphoblastic leukemia]Yan-rong Liu, Le-ping Zhang, Yan Chang, et al.
Transplantation and Cellular Therapy|February 10, 2026
Desensitization therapy using sirolimus and anti-CD20 monoclonal antibody based regimen in haploidentical transplant recipients positive for donor-specific anti-HLA antibodiesNing Ma, Xiang-Yu Zhao, Lan-Ping Xu, et al.
Pageof 9